Company

Product

Description

Indication

Status


BTG International Canada Inc., of Ottawa, Ontario, a subsidairy of BTG plc, of London

Icefx Cryoablation System

Portable, minimally invasive system

Provides cryotherapy ablation in cancer patients

Received a medical device license from Health Canada

Edwards Lifesciences Corp., of Irvine, Calif.

Sapien 3 and Sapien 3 Ultra

Transcatheter heart valve systems

The treatment of severe, symptomatic aortic stenosis patients who are determined to be at low risk of open-heart surgery

Received U.S. FDA approval to expand use

Medtronic plc, of Dublin

Corevalve Evolut R and Corevalve Evolut PRO

Transcatheter heart valve systems

The treatment of severe, symptomatic aortic stenosis patients who are determined to be at low risk of open-heart surgery

Received U.S. FDA approval to expand use

Oncology Venture A/S, of Hoersholm, Denmark

Liplacis DRP

Drug response predictor (DRP)

Treatment of metastatic breast cancer in heavily pre-treated patients

The U.S. FDA approved an investigational device exemption application for phase III study

Zimmer Biomet Holdings Inc., Warsaw, Ind.

The Tether

Spinal tether device

Treatment of scoliosis

Gained U.S. FDA approval


Notes

For more information about individual companies and/or products, see Cortellis.

No Comments